v3.25.2
SHAREHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2025
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Stock Options Granted
   
Six months ended
June 30, 2025
 
   
Number
of options
   
Weighted
average
exercise
price
   
Weighted average remaining contractual term
(in years)
   
Aggregate
intrinsic
value
 
                     
$ thousands
 
                         
Outstanding at beginning of year
   
3,723,286
     
2.52
     
4.06
     
8,005
 
Granted
   
973,783
     
2.63
                 
Exercised
   
(267,765
)
   
2.44
                 
Forfeited or expired
   
(222,098
)
   
2.21
                 
                                 
Outstanding at end of the period
   
4,207,206
     
2.57
     
4.12
     
603
 
                                 
Options exercisable at end of the period
   
1,946,843
     
2.58
     
3.60
     
323
 
                                 
Vested and expected to vest
   
3,752,649
     
2.57
     
4.01
     
560
 
Schedule of RSUs Granted
   
Six months ended
June 30, 2025
 
   
Number of RSUs
   
Weighted average fair value
 
Unvested at beginning of year
   
2,723,042
     
2.43
 
Granted
   
878,190
     
2.47
 
Vested
   
(360,637
)
   
2.26
 
Forfeited
   
(322,424
)
   
2.40
 
                 
Unvested at end of period
   
2,918,171
     
2.47
 
Schedule of Equity-Based Compensation Expense
   
Six months ended
June 30
 
   
2025
   
2024
 
   
$ thousands
   
$ thousands
 
Cost of revenues
   
189
     
265
 
Research and development
   
278
     
336
 
Sales and Marketing
   
640
     
683
 
General and administrative
   
1,092
     
1,186
 
                 
Total share-based compensation expense
   
2,199
     
2,470